Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 1/2014

01-02-2014

The Effects of Opioids on the Lung

Authors: Joshua B. Radke, Kelly P. Owen, Mark E. Sutter, Jonathan B. Ford, Timothy E. Albertson

Published in: Clinical Reviews in Allergy & Immunology | Issue 1/2014

Login to get access

Abstract

The term opioid refers to a broad class of medications that are used most frequently for their analgesic effects. Along with this effect, they also produce euphoria, and it is for this reason that they have been used illicitly, as well as medicinally, for thousands of years. While the most well-known complications of opioid use and misuse include respiratory and central nervous system depression, there are many other toxicities that have been associated with these drugs. Many complications can occur with multiple different opioids, such as non-cardiogenic pulmonary edema, while many of the complications are unique to the opioid used as well as the route of administration. This review focuses on the pulmonary complications associated with opioid use and abuse, but opioids can affect nearly every organ system. Their effects on the pulmonary system can be direct, such as causing granulomatous change, but they can also work indirectly. For example, opioids cause respiratory depression by decreasing sensitivity of peripheral chemoreceptors to carbon dioxide and decreasing activity in the central respiratory centers. Opioids have also been reported to affect the immune system, and place users at increased risk for many different infectious complications. Patients can have a wide array of signs and symptoms, sometimes making it difficult to recognize opioids as a cause for a patient’s clinical picture. Due to the sedative effects of opioids, patients are also often not able to provide a reliable history. Knowledge of the possible toxicities of opioids can help prepare a physician to recognize the many complications associated with opioid use.
Literature
2.
go back to reference Nelson L, Lewin N, Howland MA, Hoffman R, Flomenbaum N (2007) Opioids, in Goldfrank's toxicologic emergencies by Lewis Goldfrank, 9th edn. McGraw-Hill Medical Pub, New York, pp 483–499 Nelson L, Lewin N, Howland MA, Hoffman R, Flomenbaum N (2007) Opioids, in Goldfrank's toxicologic emergencies by Lewis Goldfrank, 9th edn. McGraw-Hill Medical Pub, New York, pp 483–499
3.
go back to reference Center for Behavioral Health Statistics and Quality (2010) Results from the 2010 national survey on drug use and health: summary of national findings. Results from the 2010 NSDUH: Summary of National Findings, SAMHSA, CBHSQ Center for Behavioral Health Statistics and Quality (2010) Results from the 2010 national survey on drug use and health: summary of national findings. Results from the 2010 NSDUH: Summary of National Findings, SAMHSA, CBHSQ
4.
go back to reference Manchikanti L, Helm S II, Fellows B et al (2012) Opioid epidemic in the United States. Pain Phys J 15:ES9–S38 Manchikanti L, Helm S II, Fellows B et al (2012) Opioid epidemic in the United States. Pain Phys J 15:ES9–S38
6.
go back to reference Koob G (2004) Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27:739–749PubMedCrossRef Koob G (2004) Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27:739–749PubMedCrossRef
7.
go back to reference Selley DE, Cao CC, Sexton T, Schwegel JA, Martin TJ, Childers SR (2001) Mu opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem Pharmacol 62:447–455PubMedCrossRef Selley DE, Cao CC, Sexton T, Schwegel JA, Martin TJ, Childers SR (2001) Mu opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem Pharmacol 62:447–455PubMedCrossRef
8.
go back to reference Bishay A, Amchentsev A, Saleh A, Patel N, Travis W, Raoof S (2008) A hitherto unreported pulmonary complication in an IV heroin user. Chest 133:549–551PubMedCrossRef Bishay A, Amchentsev A, Saleh A, Patel N, Travis W, Raoof S (2008) A hitherto unreported pulmonary complication in an IV heroin user. Chest 133:549–551PubMedCrossRef
9.
go back to reference Dettmeyer RB, Verhoff MA, Brückel B, Walter D (2010) Widespread pulmonary granulomatosis following long time intravenous drug abuse—a case report. Forensic Sci Int 197:E27–30PubMedCrossRef Dettmeyer RB, Verhoff MA, Brückel B, Walter D (2010) Widespread pulmonary granulomatosis following long time intravenous drug abuse—a case report. Forensic Sci Int 197:E27–30PubMedCrossRef
10.
go back to reference Arnett EN, William E, Battle RJV, Roberts WC (1976) Intravenous injection of talc-containing drugs intended for oral use: a cause of pulmonary granulomatosis and pulmonary hypertension. Am J Med 60:711–718PubMedCrossRef Arnett EN, William E, Battle RJV, Roberts WC (1976) Intravenous injection of talc-containing drugs intended for oral use: a cause of pulmonary granulomatosis and pulmonary hypertension. Am J Med 60:711–718PubMedCrossRef
12.
go back to reference Orangio GR, Pitlick SD, Della Latta P et al (1984) Soft tissue infections in parenteral drug abusers. Ann Surg 199:97–100PubMedCrossRef Orangio GR, Pitlick SD, Della Latta P et al (1984) Soft tissue infections in parenteral drug abusers. Ann Surg 199:97–100PubMedCrossRef
13.
go back to reference Murphy EL, DeVita D, Liu H et al (2001) Risk factors for skin and soft tissue abscesses among injection drug users: a case control study. Clin Infect Dis 33:35–40PubMedCrossRef Murphy EL, DeVita D, Liu H et al (2001) Risk factors for skin and soft tissue abscesses among injection drug users: a case control study. Clin Infect Dis 33:35–40PubMedCrossRef
14.
go back to reference Grassin-Delyle S, Buenestado A, Naline E et al (2012) Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther 34:366–379CrossRef Grassin-Delyle S, Buenestado A, Naline E et al (2012) Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther 34:366–379CrossRef
15.
go back to reference Huang HC (2009) Transnasal butorphanol for pain relief after uvulopalatopharyngoplasty—a hospital-based, randomized study. Chang Gung Med J 32:390–399PubMed Huang HC (2009) Transnasal butorphanol for pain relief after uvulopalatopharyngoplasty—a hospital-based, randomized study. Chang Gung Med J 32:390–399PubMed
16.
go back to reference Desjardins P (2000) Analgesic efficacy of intranasal butorphanol (Stadol NS) in the treatment of pain after dental impaction surgery. J Oral Maxillofac Surg 58:19–26PubMedCrossRef Desjardins P (2000) Analgesic efficacy of intranasal butorphanol (Stadol NS) in the treatment of pain after dental impaction surgery. J Oral Maxillofac Surg 58:19–26PubMedCrossRef
17.
go back to reference Greene D (2005) Total necrosis of the intranasal structures and soft palate as a result of nasal inhalation of crushed OxyContin. Ear Nose Throat J 84(8):512–516PubMed Greene D (2005) Total necrosis of the intranasal structures and soft palate as a result of nasal inhalation of crushed OxyContin. Ear Nose Throat J 84(8):512–516PubMed
18.
go back to reference Lofwall MR, Moody DE, Fang WB, Nuzzo PA, Walsh SL (2012) Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers. J Clin Pharmacol 52:600–606PubMedCrossRef Lofwall MR, Moody DE, Fang WB, Nuzzo PA, Walsh SL (2012) Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers. J Clin Pharmacol 52:600–606PubMedCrossRef
19.
go back to reference Kass-Hout T, Kass-Hout O, Darkhabani MZ, Mokin M, Mehta B, Radovic V (2011) “Chasing the dragon”—heroin-associated spongiform leukoencephalopathy. J Med Toxicol 7:240–242PubMedCentralPubMedCrossRef Kass-Hout T, Kass-Hout O, Darkhabani MZ, Mokin M, Mehta B, Radovic V (2011) “Chasing the dragon”—heroin-associated spongiform leukoencephalopathy. J Med Toxicol 7:240–242PubMedCentralPubMedCrossRef
20.
go back to reference Wolters E (1982) Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet 320:1233–1237CrossRef Wolters E (1982) Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet 320:1233–1237CrossRef
21.
go back to reference Prowse SJ, Lima T, Irion KL, Burhan H, Hochhegger B, Marchiori E (2011) Valsalva manoeuvre effect on distribution of lung damage in heroin inhalation. Br J Radiol 84:E200–201PubMedCrossRef Prowse SJ, Lima T, Irion KL, Burhan H, Hochhegger B, Marchiori E (2011) Valsalva manoeuvre effect on distribution of lung damage in heroin inhalation. Br J Radiol 84:E200–201PubMedCrossRef
22.
go back to reference Chapman E, Leipsic J, Satkunam N, Churg A (2012) Pulmonary alveolar proteinosis as a reaction to fentanyl patch smoke. Chest 141:1321–1323PubMedCrossRef Chapman E, Leipsic J, Satkunam N, Churg A (2012) Pulmonary alveolar proteinosis as a reaction to fentanyl patch smoke. Chest 141:1321–1323PubMedCrossRef
23.
go back to reference Mrvos R, Feuchter A, Katz K, Duback-Morris L, Brooks D, Krenzeolak E (2012) Whole fentanyl patch ingestion: a multi-center case series. J Emerg Med 42:549–552PubMedCrossRef Mrvos R, Feuchter A, Katz K, Duback-Morris L, Brooks D, Krenzeolak E (2012) Whole fentanyl patch ingestion: a multi-center case series. J Emerg Med 42:549–552PubMedCrossRef
24.
go back to reference Barrueto F Jr, Howland MA, Hoffman RS, Nelson LS (2004) The fentanyl tea bag. Vet Hum Toxicol 46:30–31PubMed Barrueto F Jr, Howland MA, Hoffman RS, Nelson LS (2004) The fentanyl tea bag. Vet Hum Toxicol 46:30–31PubMed
25.
go back to reference Janssen Pharmaceutical Inc. (2012) Duragesic: fentanyl transdermal system. Web Janssen Pharmaceutical Inc. (2012) Duragesic: fentanyl transdermal system. Web
26.
go back to reference Carson HJ, Knight LD, Dudley MH, Garg U (2010) A fatality involving an unusual route of fentanyl delivery: chewing and aspirating the transdermal patch. Legal Med 12:157–159PubMedCrossRef Carson HJ, Knight LD, Dudley MH, Garg U (2010) A fatality involving an unusual route of fentanyl delivery: chewing and aspirating the transdermal patch. Legal Med 12:157–159PubMedCrossRef
27.
go back to reference Miller DR, Harden JL, Currie GP (2006) A case of self-inflicted bilateral pneumothorax. Resuscitation 71:122–123PubMedCrossRef Miller DR, Harden JL, Currie GP (2006) A case of self-inflicted bilateral pneumothorax. Resuscitation 71:122–123PubMedCrossRef
28.
go back to reference Corzo JE, Lozano De Leon F, Gomez-Mateos J, Lopez-Cortes L, Vazquez R, Garcia-Bragado F (1992) Pneumothorax secondary to septic pulmonary emboli in tricuspid endocarditis. Thorax 47:1080–1081PubMedCrossRef Corzo JE, Lozano De Leon F, Gomez-Mateos J, Lopez-Cortes L, Vazquez R, Garcia-Bragado F (1992) Pneumothorax secondary to septic pulmonary emboli in tricuspid endocarditis. Thorax 47:1080–1081PubMedCrossRef
29.
30.
31.
go back to reference Alexander D, Alexander K, Valentino J (2012) Intranasal hydrocodone-acetaminophen abuse induced necrosis of the nasal cavity and pharynx. Laryngoscope 122:2378–2381PubMedCentralPubMedCrossRef Alexander D, Alexander K, Valentino J (2012) Intranasal hydrocodone-acetaminophen abuse induced necrosis of the nasal cavity and pharynx. Laryngoscope 122:2378–2381PubMedCentralPubMedCrossRef
32.
go back to reference Yewell J, Haydon R, Archer S, Manaligod JM (2002) Complications of intranasal prescription narcotic abuse. Ann Otol Rhinol Laryngol 111:174–177PubMed Yewell J, Haydon R, Archer S, Manaligod JM (2002) Complications of intranasal prescription narcotic abuse. Ann Otol Rhinol Laryngol 111:174–177PubMed
33.
go back to reference Hillstrom RP, Cohn AM, McCarroll KA (1990) Vocal cord paralysis resulting from neck injections in the intravenous drug use population. Laryngoscope 100:503–506PubMedCrossRef Hillstrom RP, Cohn AM, McCarroll KA (1990) Vocal cord paralysis resulting from neck injections in the intravenous drug use population. Laryngoscope 100:503–506PubMedCrossRef
36.
go back to reference Santiago TV, Edelman NH (1985) Opioids and breathing. J Appl Physiol 59:1675–1685PubMed Santiago TV, Edelman NH (1985) Opioids and breathing. J Appl Physiol 59:1675–1685PubMed
37.
go back to reference Jungquist C, Flannery M, Perlis ML, Grace JT (2012) Relationship of chronic pain and opioid use with respiratory disturbance during sleep. Pain Manag Nurs 13:70–79PubMedCrossRef Jungquist C, Flannery M, Perlis ML, Grace JT (2012) Relationship of chronic pain and opioid use with respiratory disturbance during sleep. Pain Manag Nurs 13:70–79PubMedCrossRef
38.
go back to reference Glick C, Evans OB, Parks BR (1996) Muscle rigidity due to fentanyl infusion in the pediatric patient. South Med J 89:1119–1120PubMedCrossRef Glick C, Evans OB, Parks BR (1996) Muscle rigidity due to fentanyl infusion in the pediatric patient. South Med J 89:1119–1120PubMedCrossRef
39.
go back to reference Streisand JB, Bailey PL, LeMaire L et al (1993) Fentanyl-induced rigidity and unconsciousness in human volunteers incidence, duration, and plasma concentrations. Anesthesiology 78:629–634PubMedCrossRef Streisand JB, Bailey PL, LeMaire L et al (1993) Fentanyl-induced rigidity and unconsciousness in human volunteers incidence, duration, and plasma concentrations. Anesthesiology 78:629–634PubMedCrossRef
40.
41.
go back to reference Van Der Lee R, Ceelie I, De Wildt SN (2009) Morphine-induced muscle rigidity in a term neonate. Ann Pharmacother 43:1724–1726PubMedCrossRef Van Der Lee R, Ceelie I, De Wildt SN (2009) Morphine-induced muscle rigidity in a term neonate. Ann Pharmacother 43:1724–1726PubMedCrossRef
42.
go back to reference Goldstein D, Karpel J, Appel D, Williams M (1986) Bullous pulmonary damage in users of intravenous drugs. Chest 89:266–269PubMedCrossRef Goldstein D, Karpel J, Appel D, Williams M (1986) Bullous pulmonary damage in users of intravenous drugs. Chest 89:266–269PubMedCrossRef
43.
go back to reference Da Costa JL, Tock EPC, Boey HK (1971) Lung disease with chronic obstruction in opium smokers in Singapore: clinical, electrocardiographic, radiological, functional, and pathological features. Thorax 26:555–571PubMedCrossRef Da Costa JL, Tock EPC, Boey HK (1971) Lung disease with chronic obstruction in opium smokers in Singapore: clinical, electrocardiographic, radiological, functional, and pathological features. Thorax 26:555–571PubMedCrossRef
44.
go back to reference Buster MCA, Van Den Brink W, Van Brussel GHA, Van Ree JM (2011) Influence of treatment with inhalable heroin on pulmonary function. Eur Addict Res 17:136–138PubMedCrossRef Buster MCA, Van Den Brink W, Van Brussel GHA, Van Ree JM (2011) Influence of treatment with inhalable heroin on pulmonary function. Eur Addict Res 17:136–138PubMedCrossRef
45.
go back to reference Buster MCA, Rook L, Van Brussel GHA, Van Ree J, Van Den Brink W (2002) Chasing the dragon, related to the impaired lung function among heroin users. Drug Alcohol Depend 68:221–228PubMedCrossRef Buster MCA, Rook L, Van Brussel GHA, Van Ree J, Van Den Brink W (2002) Chasing the dragon, related to the impaired lung function among heroin users. Drug Alcohol Depend 68:221–228PubMedCrossRef
46.
go back to reference Mell HK, Sztajnkrycer MD (2006) Clinical images in medical toxicology: heroin overdose with non-cardiogenic pulmonary edema. Clin Toxicol 44:399CrossRef Mell HK, Sztajnkrycer MD (2006) Clinical images in medical toxicology: heroin overdose with non-cardiogenic pulmonary edema. Clin Toxicol 44:399CrossRef
47.
go back to reference Sterrett C (2003) Patterns of presentation in heroin overdose resulting in pulmonary edema. Am J Emerg Med 21:32–34PubMedCrossRef Sterrett C (2003) Patterns of presentation in heroin overdose resulting in pulmonary edema. Am J Emerg Med 21:32–34PubMedCrossRef
48.
go back to reference Horng HC, Ho MT, Huang CH, Yeh CC, Cherng CH (2010) Negative pressure pulmonary edema following naloxone administration in a patient with fentanyl-induced respiratory depression. Acta Anaesthesiol Taiwan 48:155–157PubMedCrossRef Horng HC, Ho MT, Huang CH, Yeh CC, Cherng CH (2010) Negative pressure pulmonary edema following naloxone administration in a patient with fentanyl-induced respiratory depression. Acta Anaesthesiol Taiwan 48:155–157PubMedCrossRef
49.
go back to reference Hamilton RJ, Olmedo RE, Shah S et al (2002) Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets. Acad Emerg Med 9:63–68PubMedCrossRef Hamilton RJ, Olmedo RE, Shah S et al (2002) Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets. Acad Emerg Med 9:63–68PubMedCrossRef
50.
go back to reference Kienbaum P, Thurauf N, Michel MC, Scherbaum N, Gastpar M, Peters J (1998) Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology 88:1154–1161PubMedCrossRef Kienbaum P, Thurauf N, Michel MC, Scherbaum N, Gastpar M, Peters J (1998) Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology 88:1154–1161PubMedCrossRef
51.
go back to reference Frand U, Shim C, Williams H (1972) Heroin-induced pulmonary edema: sequential studies of pulmonary function. Ann Intern Med 77:29–35PubMedCrossRef Frand U, Shim C, Williams H (1972) Heroin-induced pulmonary edema: sequential studies of pulmonary function. Ann Intern Med 77:29–35PubMedCrossRef
52.
go back to reference Sporer KA (2001) Heroin-related noncardiogenic pulmonary edema: a case series. Chest 120:1628–1632PubMedCrossRef Sporer KA (2001) Heroin-related noncardiogenic pulmonary edema: a case series. Chest 120:1628–1632PubMedCrossRef
54.
go back to reference Griffith C, Raval J, Nichols L (2012) Intravascular talcosis due to intravenous drug use is an underrecognized cause of pulmonary hypertension. Pulmonary Medicine (in press) Griffith C, Raval J, Nichols L (2012) Intravascular talcosis due to intravenous drug use is an underrecognized cause of pulmonary hypertension. Pulmonary Medicine (in press)
55.
go back to reference Kringsholm B, Christoffersen P (1987) The nature and the occurrence of birefringent material in different organs in fatal drug addiction. Forensic Sci Int 34:53–62PubMedCrossRef Kringsholm B, Christoffersen P (1987) The nature and the occurrence of birefringent material in different organs in fatal drug addiction. Forensic Sci Int 34:53–62PubMedCrossRef
56.
go back to reference Marchiori E, Lourenço S, Gasparetto TD, Zanetti G, Mano CM, Nobre LF (2010) Pulmonary talcosis: imaging findings. Lung 188:165–171PubMedCrossRef Marchiori E, Lourenço S, Gasparetto TD, Zanetti G, Mano CM, Nobre LF (2010) Pulmonary talcosis: imaging findings. Lung 188:165–171PubMedCrossRef
57.
go back to reference Davis LL (1983) Pulmonary "mainline" granulomatosis: talcosis secondary to intravenous heroin abuse with characteristic X-ray findings of asbestosis. J Natl Med Assoc 75:1225–1228PubMed Davis LL (1983) Pulmonary "mainline" granulomatosis: talcosis secondary to intravenous heroin abuse with characteristic X-ray findings of asbestosis. J Natl Med Assoc 75:1225–1228PubMed
58.
go back to reference Randall D, Degenhardt L, Vajdic CM et al (2011) Increasing cancer mortality among opioid-dependent persons in Australia: a new public health challenge for a disadvantaged population. Aust N Z J Public Health 35:220–225PubMedCrossRef Randall D, Degenhardt L, Vajdic CM et al (2011) Increasing cancer mortality among opioid-dependent persons in Australia: a new public health challenge for a disadvantaged population. Aust N Z J Public Health 35:220–225PubMedCrossRef
59.
go back to reference Gach K, Wyrębska A, Fichna J, Janecka A (2011) The role of morphine in regulation of cancer cell growth. Naunyn-Schmiedeberg's Arch Pharmacol 384:221–230CrossRef Gach K, Wyrębska A, Fichna J, Janecka A (2011) The role of morphine in regulation of cancer cell growth. Naunyn-Schmiedeberg's Arch Pharmacol 384:221–230CrossRef
60.
61.
62.
go back to reference Cygan J (2000) Inhaled heroin-induced status asthmaticus: five cases and a review of the literature. Chest 117:272–275PubMedCrossRef Cygan J (2000) Inhaled heroin-induced status asthmaticus: five cases and a review of the literature. Chest 117:272–275PubMedCrossRef
63.
go back to reference Withington DE, Patrick JA, Reynolds F (1993) Histamine release by morphine and diamorphine in man. Anaesthesia 48:26–29PubMedCrossRef Withington DE, Patrick JA, Reynolds F (1993) Histamine release by morphine and diamorphine in man. Anaesthesia 48:26–29PubMedCrossRef
64.
go back to reference Tsapas A, Paletas K, Vlachaki E, Bekiari E, Spanos C, Economidis D (2008) Eosinophilic pneumonia associated with heroin inhalation: a case report. Wien Klin Wochenschr 120:178–180PubMedCrossRef Tsapas A, Paletas K, Vlachaki E, Bekiari E, Spanos C, Economidis D (2008) Eosinophilic pneumonia associated with heroin inhalation: a case report. Wien Klin Wochenschr 120:178–180PubMedCrossRef
65.
go back to reference Banerjee A, Strazza M, Wigdahl B, Pirrone V, Meucci O, Nonnemacher MR (2011) Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis. J Neurovirol 17:291–302PubMedCentralPubMedCrossRef Banerjee A, Strazza M, Wigdahl B, Pirrone V, Meucci O, Nonnemacher MR (2011) Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis. J Neurovirol 17:291–302PubMedCentralPubMedCrossRef
66.
68.
go back to reference Wang J, Barke RA, Charboneau R, Roy S (2005) Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 174:426–434PubMed Wang J, Barke RA, Charboneau R, Roy S (2005) Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 174:426–434PubMed
69.
go back to reference Rittner HL, Roewer N, Brack A (2010) The clinical (ir)relevance of opioid-induced immune suppression. Curr Opin Anaesthesiol 23:588–592PubMedCrossRef Rittner HL, Roewer N, Brack A (2010) The clinical (ir)relevance of opioid-induced immune suppression. Curr Opin Anaesthesiol 23:588–592PubMedCrossRef
70.
go back to reference Kaushik KS, Kapila K, Praharaj AK (2011) Shooting up: the interface of microbial infections and drug abuse. J Med Microbiol 60:4084–22CrossRef Kaushik KS, Kapila K, Praharaj AK (2011) Shooting up: the interface of microbial infections and drug abuse. J Med Microbiol 60:4084–22CrossRef
71.
go back to reference Dublin S, Walker RL, Jackson ML et al (2011) Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case–control study. J Am Geriatr Soc 59:1899–1907PubMedCentralPubMedCrossRef Dublin S, Walker RL, Jackson ML et al (2011) Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case–control study. J Am Geriatr Soc 59:1899–1907PubMedCentralPubMedCrossRef
72.
go back to reference Jain V, Yang M, Kovacicovalezcano G, Juhle L, Bolger A, Winston L (2008) Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement. J Infect 57:132–138PubMedCrossRef Jain V, Yang M, Kovacicovalezcano G, Juhle L, Bolger A, Winston L (2008) Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement. J Infect 57:132–138PubMedCrossRef
73.
go back to reference Dettmeyer R, Friedrich K, Schmidt P, Madea B (2009) Heroin-associated Myocardial damages—conventional and immunohistochemical investigations. Forensic Sci Int 187:42–46PubMedCrossRef Dettmeyer R, Friedrich K, Schmidt P, Madea B (2009) Heroin-associated Myocardial damages—conventional and immunohistochemical investigations. Forensic Sci Int 187:42–46PubMedCrossRef
74.
go back to reference Fowler VG, Miro JM, Hoen B et al (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012–3021PubMedCrossRef Fowler VG, Miro JM, Hoen B et al (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012–3021PubMedCrossRef
76.
go back to reference Tan LKK, Powrie DJ, Rowland R, Cropley I, Lipman M (2007) Fever and haemoptysis in an injecting drug user. Eur Respir J 29:1061–1063PubMedCrossRef Tan LKK, Powrie DJ, Rowland R, Cropley I, Lipman M (2007) Fever and haemoptysis in an injecting drug user. Eur Respir J 29:1061–1063PubMedCrossRef
77.
go back to reference O'Donnell A, Pappas L (1988) Pulmonary complications of intravenous drug abuse. Experience at an inner-city hospital. Chest 94:251–253PubMedCrossRef O'Donnell A, Pappas L (1988) Pulmonary complications of intravenous drug abuse. Experience at an inner-city hospital. Chest 94:251–253PubMedCrossRef
78.
go back to reference O'Donnell AE, Selig J, Aravamuthan M, Richardson MS (1995) Pulmonary complications associated with illicit drug use: an update. Chest 108:460–463PubMedCrossRef O'Donnell AE, Selig J, Aravamuthan M, Richardson MS (1995) Pulmonary complications associated with illicit drug use: an update. Chest 108:460–463PubMedCrossRef
79.
go back to reference Grenfell P, Leite RB, Garfein R, Lussigny S, Platt L, Rhodes T (2013) Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature. Drug Alcohol Depend 129:180–209PubMedCrossRef Grenfell P, Leite RB, Garfein R, Lussigny S, Platt L, Rhodes T (2013) Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature. Drug Alcohol Depend 129:180–209PubMedCrossRef
80.
go back to reference Palmateer NE, Hope VD, Roy K et al (2013) Infections with spore-forming bacteria in persons who inject drugs, 2000–2009. Emerg Infect Dis 19:29–34PubMedCrossRef Palmateer NE, Hope VD, Roy K et al (2013) Infections with spore-forming bacteria in persons who inject drugs, 2000–2009. Emerg Infect Dis 19:29–34PubMedCrossRef
81.
go back to reference Yuan J, Inami G, Mohle-Boetani J, Vugia DJ (2011) Recurrent wound botulism among injection drug users in California. Clin Infect Dis 52:862–866PubMedCrossRef Yuan J, Inami G, Mohle-Boetani J, Vugia DJ (2011) Recurrent wound botulism among injection drug users in California. Clin Infect Dis 52:862–866PubMedCrossRef
82.
go back to reference Kimura A, Higa J, Levin R, Simpson G, Vargas Y, Vugia D (2004) Outbreak of Necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis 38:E87–91PubMedCrossRef Kimura A, Higa J, Levin R, Simpson G, Vargas Y, Vugia D (2004) Outbreak of Necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis 38:E87–91PubMedCrossRef
83.
go back to reference Passaro D, Werner B, McGee J, MacKenzie W, Vugia D (1998) Wound botulism associated with black tar heroin among injecting drug users. JAMA 279:859–863PubMedCrossRef Passaro D, Werner B, McGee J, MacKenzie W, Vugia D (1998) Wound botulism associated with black tar heroin among injecting drug users. JAMA 279:859–863PubMedCrossRef
84.
go back to reference Shuster S (2011) The curse of the crocodile: Russia's deadly designer drug. Time. Web Shuster S (2011) The curse of the crocodile: Russia's deadly designer drug. Time. Web
85.
go back to reference Gahr M, Freudenmann RW, Heimke C, Gunst IM, Connemann BJ, Schonfeldt-Lecuona C (2012) Desomorphine goes "crocodile.". J Addict Dis 31:407–412PubMedCrossRef Gahr M, Freudenmann RW, Heimke C, Gunst IM, Connemann BJ, Schonfeldt-Lecuona C (2012) Desomorphine goes "crocodile.". J Addict Dis 31:407–412PubMedCrossRef
86.
go back to reference Hassan Z, Muzaimi M, Navaratnam V et al (2013) From kratom to mitragynine and its derivatives: physiological and behavioral effects related to use, abuse, and addiction. Neurosci Biobehav Rev 37:138–151PubMedCrossRef Hassan Z, Muzaimi M, Navaratnam V et al (2013) From kratom to mitragynine and its derivatives: physiological and behavioral effects related to use, abuse, and addiction. Neurosci Biobehav Rev 37:138–151PubMedCrossRef
87.
go back to reference Kronstrand R, Roman M, Thelander G, Eriksson A (2011) Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend krypton. J Anal Toxicol 35:242–247PubMedCrossRef Kronstrand R, Roman M, Thelander G, Eriksson A (2011) Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend krypton. J Anal Toxicol 35:242–247PubMedCrossRef
88.
go back to reference Siavash M, Janghorbani M, Gheshlaghi F et al (2009) A case series of abuse of a new opioid combination, norjizak. J Addict Dis 28:180–185PubMedCrossRef Siavash M, Janghorbani M, Gheshlaghi F et al (2009) A case series of abuse of a new opioid combination, norjizak. J Addict Dis 28:180–185PubMedCrossRef
Metadata
Title
The Effects of Opioids on the Lung
Authors
Joshua B. Radke
Kelly P. Owen
Mark E. Sutter
Jonathan B. Ford
Timothy E. Albertson
Publication date
01-02-2014
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 1/2014
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-013-8373-z

Other articles of this Issue 1/2014

Clinical Reviews in Allergy & Immunology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.